[CYCC] QoQ Quarter Result on 30-Sep-2011 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Nov-2011
Financial Year
2011
Quarter
30-Sep-2011 [#Q3]
Profit Trend
QoQ- 3.01%
YoY- 9.51%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
Revenue 146 161 175 164 168 192 138 3.83%
PBT -3,704 -3,123 -3,780 -3,571 -3,678 -4,779 -3,323 7.51%
Tax -127 -168 -122 -126 -126 -191 -151 -10.90%
NP -3,577 -2,955 -3,658 -3,445 -3,552 -4,588 -3,172 8.34%
Tax Rate - - - - - - - -
Total Cost 3,723 3,116 3,833 3,609 3,720 4,780 3,310 8.16%
Ratio Analysis
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
NP Margin -2,450.00 -1,835.40 -2,090.29 -2,100.61 -2,114.29 -2,389.58 -2,298.55 4.34%
Per Share
30/06/12 31/03/12 31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 CAGR
EPS -101.86 -90.66 -113.25 -107.75 -128.11 -165.51 -115.84 -8.22%
EPS Diluted -101.86 -90.66 -112.22 -107.75 -128.11 -165.51 -114.43 -7.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.